Announced
Completed
Synopsis
Temasek, a Singapore-based investment firm, completed the $85m investment in Molbio Diagnostics, a healthcare solutions provider. "These funds from the minority stake investment will be used for domestic and external business development, overseas market expansion, and research and development," Sriram Natarajan, Molbio Diagnostics Director and CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.